← All trials
NCT02075216
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2013
- Primary completion
- Nov 1, 2015
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Al Azhar UniversityLead sponsor
- Al Azhar UniversityStudy chair
- Al Azhar UniversityStudy director
- Cairo UniversityCollaborator
- Al Azhar UniversityOverall official - principal investigator
- Al Azhar UniversityReponsible party - principal investigator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.